Brivaracetam

Brivaracetam(UCB-34714) is an antiepileptic compound that is a ligand for synaptic vesicle glycoprotein 2A (SV2A; Kd = 50 nM for human SV2A in vitro). Brivaracetam displays selectivity for SV2A at 10 μM, against a panel of 55 receptors, enzymes, ion channels and transporters.


Cat. No.: EX-A2748	Purity: >99%

	Chemical structure of Brivaracetam

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	165	In-stock
250mg	268	In-stock
500mg	376	In-stock
1g	685	In-stock
5g	1685	In-stock
10g	2450	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	UCB-34714
CAS No.	357336-20-0
Purity	>99%
Formula	C11H20N2O2
Mol Weight	212.2887
Color	white
State	solid powder
Shelf Life	>3 years if stored properly
Storage	Powder 4-8℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Gillard, Michel et al. “Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.” European journal of pharmacology vol. 664,1-3 (2011): 36-44. doi:10.1016/j.ejphar.2011.04.064 [2]. Rogawski, Michael A. “A New SV2A Ligand for Epilepsy.” Cell vol. 167,3 (2016): 587. doi:10.1016/j.cell.2016.09.057
CoA	CoA of Brivaracetam

Smiles:	CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1


		Search